Lidoflazine: Double-blind trial of a new coronary vasodilator in angina pectoris
- 1 October 1973
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 6 (3), 156-162
- https://doi.org/10.1007/bf00558279
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Prophylactic Treatment of Angina Pectoris. A Double-Blind Cross-Over Comparison of Alprenolol and PentanitrolBMJ, 1970
- Release of Adenosine by the Normal Myocardium in Dogs and Its Relationship to the Regulation of Coronary ResistanceCirculation Research, 1969
- Potentiation of Adenosine Activity by Low Oral Doses of LidoflazineNature, 1969
- TREATMENT OF ANGINA PECTORIS WITH BETA‐RECEPTOR BLOCKADE, MODE OF ACTIONActa Medica Scandinavica, 1968
- Enhancement of Coronary Vasodilating Action of ATP and Adenosine by LidoflazineCirculation Research, 1968
- The Treatment of Angina Pectoris with a New Beta‐receptor Blocking Agent (H 56/28)Acta Medica Scandinavica, 1967
- The prophylactic value of propranolol in angina pectorisThe American Journal of Cardiology, 1966
- Propranolol in the therapy of angina pectorisThe American Journal of Cardiology, 1966
- DOUBLE BLIND EVALUATION OF ORALLY ADMINISTERED IPROVERATRIL IN PATIENTS WITH ANGINA PECTORISThe American Journal of the Medical Sciences, 1966
- Double-blind Trail to Propranolol (Inderal) in Angina PectorisBMJ, 1965